Early Access — free while we kick the tires
EdgarHawk

Mulligan Richard

Director

Director
1 filing analyzed · 1 company · Latest 2024-09-26

Never miss a filing from Mulligan Richard

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Sana Biotechnology, Inc. SANA 0 2 Net selling

Activity

September 2024
high
Sell
300,000 shares
$1,195,740
Significance 7/10

Director Mulligan Richard sold 300,000 shares (10.0% of holdings) across 2 transactions at $4.08–$3.89, while SANA trades 62.1% below 52-week high amid $-50.3M annual losses.

Director Mulligan Richard executed two separate sales totaling 300,000 shares for $1,195,740.00 on consecutive trading days (2024-09-24 and 2024-09-25) at a blended average price of $3.99. The sales reduced his holdings from 2,998,121 shares to 2,698,121 shares. This activity occurs against a backdrop of significant operational losses (net income $-50,291,000.00 for the most recent full fiscal year) and sharp stock price depreciation: SANA trades at $4.27, representing a 62.1% decline from the 52-week high of $11.27 and a 26.1% drop over the prior 30 days. The combination of discretionary sales by a director during a period of negative profitability and pronounced downward price momentum deserves investor scrutiny regarding insider confidence in the company's near-term trajectory.

Related insiders